Lipodystrophy--nukes vs. protease inhibitors.
D000273:Adipose Tissue; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D019247:HIV Wasting Syndrome; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D019562:Viral Load
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors